|
市場調査レポート
商品コード
1239769
ウシ胎児血清の世界市場(2022年~2030年)Fetal Bovine Serum : Global Market Intelligence (2022-2030) |
||||||
ウシ胎児血清の世界市場(2022年~2030年) |
出版日: 2023年03月10日
発行: Sprout Intelligence
ページ情報: 英文 90+ Pages
納期: 即日から翌営業日
|
世界のウシ胎児血清の市場規模は、2022年から2030年にかけて8.58%のCAGRで成長し、8億米ドル以上に達すると予測されています。
当レポートでは、世界のウシ胎児血清市場について調査分析し、市場分析、市場参入企業など、体系的な情報を提供しています。
The report "Fetal Bovine Serum: Global Market Intelligence (2022-2030)" provides market intelligence on the different market segments, based on End-user type, Application and geography. Market size and forecast (2022-2030) has been provided in the report. The primary objectives of this report are to provide 1) comprehensive global market intelligence through detailed segmentation, 2) market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends, 3) detailed analysis of current dynamics and trends, key market players, and strategies in the market, 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants, 5) provide emerging opportunities in the market and the future impact of major drivers and restraints of the market and, 6) support decision makers in making cost-effective business decisions.
In our market size and forecast determination efforts, an extensive secondary research was initially completed to gain a good perspective of the market in each region. Extensive primary research was also carried out by interviewing the key executives from the industry. These interviews helped us to fill-in the data gaps after secondary research. Several secondary sources such as encyclopedia, directories, and databases have been used to identify and collect information useful for this extensive techno-commercial study. The respondents - selected experts from manufacturers and selected suppliers - have been interviewed to obtain and verify critical information as well as to assess the future prospects. The usage of obtained information is based on the perceived reliability by the research team. In many cases, a combination of several sources was used. Sprout Intelligence provides an in-depth analysis of the market segmentation, which is a critical element of the market intelligence reports at Sprout Intelligence.
Executives in marketing, strategic planning and new End-user type development will find such discussions in our reports pertinent and useful. Management consultants, investment bankers, manufacturers, distributors, suppliers, and regulatory authorities are amongst our regular clientele served.
The general data sources used in this report are company websites, trade association publications, regulatory authorities, journals, magazines, news websites, press releases, media publications, interaction with industry experts, company executives, research papers, articles, patents, scientific literature, among many others.
Fetal Bovine Serum market is expected to grow at 8.58% CAGR from 2022 to 2030.
Due to having a very low level of antibodies and containing more growth factors, allowing for versatility in many different cell culture applications, Fetal bovine serum used serum-supplement for the in vitro cell culture of eukaryotic cells.
USA, United Kingdom and Germany are the leading countries in fetal bovine serum market.
Merck Group, Thermo Fisher Scientific Inc., GE Healthcare, TCS Biosciences Ltd, Hi Media Laboratories, Atlanta Biologicals, Inc., are leading manufacturers of Fetal bovine serum.
Sprout Intelligence expert team estimated that the global Fetal bovine serum market was worth more than USD 800 million.